For the use only of a Registered Medical Practitioner or Hospital or a Laboratory.
Ranitidine Injection is indicated for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and Zollinger-Ellison syndrome. It may also be used as pre-medication prior to anaesthesia in order to reduce the volume and acid content of gastric secretion, thereby minimising the consequence of the acid aspiration syndrome.
DOSAGE AND ADMINISTRATION:
For intravenous or intramuscular injection.
Adults: Ranitidine Injection may be given either as a slow (over two minutes) intravenous injection of 50 mg, diluted to a volume of 20 mL which may be repeated every 6-8 hours, or as an intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be repeated at 6-8 hour intervals.
For pre-medication prior to anaesthesia in order to reduce the volume and acid content of gastric secretion, RANITIDINE INJECTION should be given intramuscularly or by a slow intravenous injection (over two minutes) of 50 mg diluted to a volume of 20 mL, 45-60 minutes before induction of general anaesthesia.